McKesson Other Share Holders Equity 2010-2024 | MCK

McKesson other share holders equity from 2010 to 2024. Other share holders equity can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • McKesson other share holders equity for the quarter ending September 30, 2024 was $M, a NAN% increase year-over-year.
  • McKesson other share holders equity for 2024 was $0B, a NAN% decline from 2023.
  • McKesson other share holders equity for 2023 was $0B, a NAN% decline from 2022.
  • McKesson other share holders equity for 2022 was $0B, a NAN% decline from 2021.
McKesson Annual Other Share Holders Equity
(Millions of US $)
2024 $
2023 $
2022 $
2021 $
2020 $
2019 $-2
2018 $-1
2017 $-2
2016 $-2
2015 $-7
2014 $23
2013 $14
2012 $4
2011 $10
2010 $-12
2009 $-8
McKesson Quarterly Other Share Holders Equity
(Millions of US $)
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31 $-2
2019-09-30 $-2
2019-06-30 $-1
2019-03-31 $-2
2018-12-31 $-2
2018-09-30 $-2
2018-06-30 $-1
2018-03-31 $-1
2017-12-31 $-1
2017-09-30 $-3
2017-06-30 $-4
2017-03-31 $-2
2016-12-31 $-3
2016-09-30 $-3
2016-06-30 $-3
2016-03-31 $-2
2015-12-31 $-2
2015-09-30 $-3
2015-06-30 $-4
2015-03-31 $-7
2014-12-31 $-7
2014-09-30 $-7
2014-06-30 $-7
2014-03-31 $23
2013-12-31 $16
2013-09-30 $19
2013-06-30 $17
2013-03-31 $14
2012-12-31 $14
2012-09-30 $15
2012-06-30 $12
2012-03-31 $4
2011-12-31 $6
2011-09-30 $7
2011-06-30 $5
2011-03-31 $10
2010-12-31 $2
2010-09-30 $-11
2010-06-30 $-12
2010-03-31 $-12
2009-12-31 $-12
2009-09-30 $-12
2009-06-30 $-8
2009-03-31 $-8
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $76.568B $308.951B
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $71.603B 18.76
Cardinal Health (CAH) United States $30.919B 16.77
West Pharmaceutical Services (WST) United States $24.592B 50.23
Straumann Holding AG (SAUHY) Switzerland $23.137B 0.00
Labcorp (LH) United States $20.594B 17.08
Cooper (COO) United States $19.559B 26.49
Align Technology (ALGN) United States $16.756B 32.06
Henry Schein (HSIC) United States $9.958B 18.97
Merit Medical Systems (MMSI) United States $6.322B 32.29
DENTSPLY SIRONA (XRAY) United States $3.902B 10.61
Patterson (PDCO) United States $2.733B 14.60
CONMED (CNMD) United States $2.174B 18.14
STAAR Surgical (STAA) United States $1.192B 43.98
Lifevantage (LFVN) United States $0.274B 36.50
Pro-Dex (PDEX) United States $0.141B 28.09